Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent
Landmark Agreement for New Tuberculosis Treatment SEONGNAM-SI, South Korea and NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Qurient Co. Ltd. ("Qurient", KRX: 115180), a clinical-stage biotechnology company based in South Korea, and TB Alliance, a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs, announced today that they have entered into a...
Marc-André Pépin of Invescap Announces Significant Expansion of Clinic Network
GENEVA, Feb. 2, 2023 /PRNewswire/ -- Private lending and investment firm, Invescap, has announced an expansion of its network of clinics across the US. Maintaining its deep-rooted presence in Florida, Invescap recently entered into agreements to finance medical clinics based in North Carolina, South Carolina, Georgia and Texas. With this significant expansion, the Switzerland-based firm will be providing new...
Copan Diagnostics Announces Leadership Change
CARLSBAD, Calif., Feb. 2, 2023 /PRNewswire/ -- COPAN Group announces the departure of Norman Sharples, Chief Executive Officer of Copan Diagnostics, from the Company he co-founded with Daniele Triva in 1994 and the appointment of Fabrizio Mazzocchi as new CEO and member of Copan Diagnostics' board of directors effective from January 9th, 2023. "I leave behind an organization I...
BriSTAR Immunotech to Present at the BIO CEO & Investor Conference
BEIJING and TORONTO, Feb. 2, 2023 /PRNewswire/ -- BriSTAR Immunotech, a clinical-stage cell therapy company, announced today that its Chief Executive Officer, James Pan, Ph.D., will be presenting at the 25th BIO CEO & Investor Conference. The conference will take place at the New York Marriott Marquis during February 6-9, 2023. Dr. Pan's presentation will focus on how BriSTAR's STAR-T...
Servier full year 2021/22 results confirm the transformation trajectory of the Group
Consolidated sales revenue of €4.876 billion, up 9.8% (+6.6% at CERi), driven by strong growth in international sales Sales revenue for brand-name medicines reached €3.694 billion, up 12.5% (+8.9% at CERi), and €1.182 billion for generics, up 2.0% (stable at CERi) Important developments in oncology to address high unmet medical...
SONIRE Announces First Patient Enrolled in Randomized Phase 2 Study of Its Novel HIFU Therapy System for Unresectable Pancreatic Cancer Patients in Japan
TOKYO, Feb. 2, 2023 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, announces that it has commenced a randomized phase 2 study for the treatment of unresectable pancreatic cancer with SONIRE's next-generation High-Intensity Focused Ultrasound (HIFU) therapy system (development code: Suizenji). Logo:https://kyodonewsprwire.jp/prwfile/release/M107547/202301272458/_prw_PI1fl_1823Ko1T.jpg The 5-year survival rate of pancreatic cancer is very low at 8.5%, and the number of...
Accelerating Energy Efficiency Adoption, Deep-tech Startup KrossLinker Develops a Cost-effective Aerogel Insulation
SINGAPORE, Feb. 2, 2023 /PRNewswire/ -- KrossLinker, an energy-efficiency-focused deep-tech advanced material startup, is designing and developing the world's most insulating nanomaterial, aerogel, that is low-cost, environmentally friendly, and scalable. Efficient and sustainable solutions for the most demanding insulation applications KrossLinker's first aerogel product, Cryar® Aerogel Board, targets the cold-chain industry, where...
TotalEnergies ENEOS Signs Solar Rooftop Project with Ecolite, a health and wellness company in Malaysia
KUALA LUMPUR, Malaysia, Feb. 2, 2023 /PRNewswire/ -- Ecolite Biotech Manufacturing Sdn Bhd, a health and wellness company in Malaysia, has signed a long-term agreement with TotalEnergies ENEOS to provide a 0.4 megawatt-peak (MWp) solar photovoltaic (PV) system to its facility in Malaysia. Ecolite is the subsidiary of Malaysia public-listed company Sunzen...
Chula’s Engineering Develops Dynamic Prosthetic Feet with International Standards and 5 Times Less the Cost
BANGKOK, Feb. 2, 2023 /PRNewswire/ -- Thailand now has 39,647 people with disabilities, over 95% of whom are using poor-quality prosthetic feet which are heavy and do not have ankles. This can adversely affect the way they walk, as well as their lives. The figures from the National Statistical Office of Thailand have inspired a research team...
Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)
SAN DIEGO, Feb. 2, 2023 /PRNewswire/ -- Invivoscribe is pleased to announce the appointment of Masato Sasaki as General Manager of LabPMM GK, our reference laboratory in Japan. Mr. Sasaki brings a wealth of scientific experience with him as he served at Illumina K.K. (Japan) as a leader on their clinical...
